Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.400
-0.110 (-4.38%)
May 28, 2026, 4:08 PM HKT
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.32 billion as of May 28, 2026. Its market cap has increased by 42.69% in one year.
Market Cap
1.32B
Enterprise Value
573.13M
Revenue
35.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.40
Market Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.32B, a decrease of -82.81%. That is a compound annual growth rate of -29.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 1.38B | -15.08% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.95B |
| SinoMab BioScience | 1.87B |
| Frontage Holdings | 1.85B |
| Mabpharm | 1.81B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.57B |
| Beijing Biostar Pharmaceuticals | 1.53B |
| Cutia Therapeutics | 1.51B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.47B |